The success of Viagra initially drove a period of growth for major pharmaceutical companies, but recent shifts present a murky outlook for investors. Lower-cost alternatives are eating into earnings, and persistent https://tesshnwf983337.articlesblogger.com/63571740/sildenafil-and-the-pharmaceutical-industry-a-risky-play